300677:SZSEIntco Medical Technology Co., Ltd. Class A Analysis

Intco Medical is trading at CNY 52.5, hugging the 52‑week high and the technical resistance around CNY 52.94, while the 20‑day SMA (44.32) sits well below the current price, confirming a bullish trend. MACD is bullish and volume is increasing, but the RSI of 79 signals an overbought condition that could trigger a short‑term pull‑back. Fundamentally, revenue has slipped 2.9% YoY and free cash flow is negative, yet the company holds a strong cash buffer of CNY 22.3 bn against CNY 17.8 bn of debt, resulting in a net cash position of roughly CNY 5 bn. The PE multiple of 19.7 is well under the industry average of 26.7, indicating relative cheapness, but the DCF‑derived fair value of CNY 31.9 suggests the market price is significantly overvalued. Dividend yield is modest at 0.29% with a low payout ratio of 7.5%, making the dividend sustainable despite the debt load. Overall, the stock shows strong short‑term technical momentum but faces valuation pressure and a modest growth outlook.